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Available online 8 February 2010Cervical cytobrushing is a useful and non-invasive method for obtaining mucosal mononuclear
cells from the female genital tract, but yields few cells. The aim of this study was to compare
in vitro expansion protocols (anti-CD3, anti-CD3/CD28 or Dynal anti-CD3/CD28 beads) and
cytokine combinations (IL-2, IL-7 and IL-15) to improve cervical T cell yields and viability.
Eighteen HIV-infected women were included in this study to compare methods for polyclonal
expansion of T cells from the female genital tract and blood. Comparison of T cell yields,
viability and maturational status (by differential staining with CD45RO, CCR7 and CD27) was
determined following 7 days of in vitro expansion. Anti-CD3 and IL-2 resulted in a 4.5-fold
(range 3.7–5.3) expansion of cervical CD3+ T cells in 7 days compared to day 0. Inclusion of
anti-CD28 or addition of IL-7 and IL-15 to this combination did not improve expansion.
Culturing cells with Dynal beads (1:1) and IL-2, IL-7 and IL-15 gave rise to the highest yields
after 7 days in both blood (7.1-fold) and cervix (5.6-fold). While expansion with anti-CD3 led
to the accumulation of effector memory T cells (CD45RO+CCR7−CD27−), expansion with
Dynabeads selected for accumulation of central memory T cells (CD45RO+CCR7+CD27+). We
conclude that in vitro expansion with Dynabeads (1:1) in the presence of IL-2, IL-7 and IL-15
resulted in the greatest increase in viable T cells from both blood and cytobrush. Irrespective of
the expansion method used, the T cell memory proﬁle was altered following expansion.
© 2010 Elsevier B.V.Open access under CC BY license. Keywords:
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Understanding the role of immunity in the female genital
tract in the control of HIV transmission is central to our efforts
to prevent new infections. Several approaches have been used
to isolate mononuclear cells from the genital tract, including
cervical biopsy (TOMBOLA Group, 2009) cervicovaginalisease and Molecular
th Sciences, University
Town, South Africa
Passmore).
Y license. .lavage (CVL) and cytobrushing (Coombs et al., 2001). While
cervical biopsies yield themost cells, this approach is invasive
and can compromise the integrity of the cervical surface,
inducing slow healing ulcerations (TOMBOLA Group, 2009)
which might enhance local HIV-1 replication in HIV-infected
women (Lawn et al., 2000) or increase susceptibility to
infection in uninfected women. Cervical cytobrushing and
CVL have a signiﬁcant advantage of being non-invasive
but both are constrained by the low numbers of ex vivo
lymphocytes they yield (Gumbi et al., 2008; Shacklett et al.,
2000; Kaul et al., 2000). Short-term polyclonal expansion of
T cells derived from the cervical compartment would offer a
useful approach to overcome the limitation of low cell yields
(Iqbal et al., 2005).
Table 1
Summary of the polyclonal expansion methods used.
Stimulus Cytokine cocktail References
IL-2
(IU/ml)
IL-7
(ng/ml)
IL-15
(ng/ml)
Anti-CD3 immobilized 200 – – Yang et al. (1996)
Anti-CD3 immobilized 200 20 20 Liu et al. (2006)
Anti-CD3/anti-CD28
immobilized
200 – – Levine et al.
(1996)
Dynal anti-CD3/CD28
beads (1:5) a
200 – – Kalamasz et al.
(2004)
Dynal anti-CD3/CD28
beads (1:1)
200 – – Onlamoon et al.
(2006)
Dynal anti-CD3/CD28
beads (3:1)
200 – – Kalamasz et al.
(2004)
Dynal anti-CD3/CD28
beads (1:1)
200 20 20 Onlamoon et al.
(2006)
a Anti CD3/CD28 bead-to-T cell ratios.
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including immobilized anti-CD3 (Yang et al., 1996), immo-
bilized anti-CD3 with anti-CD28 (Azuma et al., 1992;
Levine et al., 1996) or bi-speciﬁc monoclonal antibodies
directed at both CD3 and CD4 or CD8 (Jones et al., 2003). Bi-
speciﬁc antibodies are, however, not currently commer-
cially available. Recently, anti-CD3 and anti-CD28 monoclo-
nal antibodies covalently linked to super-paramagnetic
beads have been applied to expand cells (Dynabeads)
(Hippen et al., 2008; Onlamoon et al., 2006; Trickett et al.,
2002).
Distinct maturational phenotypes or ‘memory subsets’ of
T cells differ in their ability to clonally expand and become
activated following stimulation. Compared to naive T cells,
memory T cells show lower activation thresholds and
proliferate more vigorously (Sallusto et al., 2004). Further,
the expansion potential of memory subsets differs between
distinct memory classes, with central memory T cells
exhibiting the highest proliferative capacity, followed by
effector memory and then terminally differentiated memory
cells (Sallusto et al., 2004). T cells derived by cytobrush from
the female genital tract are predominantly effector memory
in phenotype (Nkwanyana et al., 2009), which is likely to
impact on the ability of these cells to expand in vitro.
While stimulation of T cells via the CD3-T cell receptor
(TCR) plays a critical role in determining the fate of T cells
(Sallusto et al., 2004), the presence of appropriate homeo-
static cytokines are likely to play a major role in driving T cell
proliferation, differentiation and survival, both in vivo (Roch-
man et al., 2009; Zhang et al., 1998; Sallusto et al., 2004) and
in vitro (Onlamoon et al., 2006). Interleukin (IL)-2 is the
predominant growth factor used to support proliferation of
T cells during in vitro expansion, with the use of concentra-
tions ranging from 20 IU/ml (Smith et al., 1995) to 1800 IU/ml
described (Winstone et al., 2009). In addition, IL-7 plays an
important role in the maintenance and antigen-independent
proliferative ability of naive T cells (Soares et al., 1998). IL-15
is essential for the homeostatic proliferation ofmemory CD8+
T cells and natural killer (NK) cells (Rochman et al., 2009) and
it has also been reported to affect the homeostasis of memory
CD4+ T cells in the absence of IL-7 (Purton et al., 2007).
Interleukin-15 shares many biological functions with IL-2
(Picker et al., 2006). Interleukin-15 can also drive antigen-
independent proliferation and differentiation of central
memory to effector memory (Geginat et al., 2003; Picker
et al., 2006).
While understanding and deﬁning protective HIV-speciﬁc
immunity in the female genital tract during HIV infection and
transmission is recognized to be important, we and others
have shown that few cells can be recovered ex vivo limiting
the depth of analysis that can be performed (Nkwanyana
et al., 2009; Gumbi et al., 2008; Shacklett et al., 2000; Kaul
et al., 2000). The aim of the present study was therefore to
compare in vitro expansion methods (anti-CD3, anti-CD3/
CD28 or Dynal anti-CD3/CD28 beads) and cytokine combina-
tions (IL-2, IL-7 and IL-15) to maximize the yield of T cells
derived from the female genital tract of women infected with
HIV-1. We identify maturational characteristics of T cells
derived from the female genital tract that may limit in vitro
expansion and investigate conditions that can be applied to
overcome this.2. Methods
2.1. Study participants
Eighteen HIV-infected women from the Nyanga Day
Hospital in Cape Town, South Africa were recruited for this
study. AllwomenhadCD4counts≥300 cells/μl andwere not on
antiretroviral therapy at the time of study. Women menstruat-
ing, who were post-menopausal, had undergone a hysterecto-
my, orhadvisible or reported evidenceof genital tract infections
or discharge were excluded from the study. All women gave
written informed consent, and the Research Ethics Committee
of theUniversity of CapeTownapproved all aspects of the study.2.2. Polyclonal expansion methods
The ability of anti-CD3, anti-CD3/anti-CD28 and Dynal
anti-CD3/CD28 beads to expand T cells in the presence of
differing combinations of IL-2, IL7 and IL-15 were compared.
Table 1 summarizes the expansion methods and cytokine
combinations used in this study. Expansions were performed
in 96-well microtitre round bottomed plates (Greiner Bio-
one; Frickenhausen, Germany). Wells were coated overnight
at 4 °C with immobilized anti-CD3 (ﬁnal concentration 10 μg/
ml; MAB100; R&D Biosystems, Minneapolis, MN, USA), either
alone or in combinationwith anti-CD28 [ﬁnal concentration of
10 μg/ml; L293, Becton Dickinson (BD) Biosciences-PharMin-
gen, San Diego, CA, USA; Azuma et al., 1992, in a ﬁnal volume
of 50 μl/well in phosphate buffered saline (GIBCO® PBS,
Invitogen™, Carlsbad, CA, USA)]. The coated plates were
washed three times with PBS to remove unbound or excess
antibody. Alternatively, Dynal magnetic beads (Dynabeads®)
coated with anti-CD3 and anti-CD28 antibodies (T cell
expander; Invitrogen Dynal, AS, Oslo, Norway; Trickett et al.,
2002) were added to wells at varying bead-to-target cell
ratios (1:5, 1:1 and 3:1) in a ﬁnal volume of 200 μl/well [cell
suspension+R10 medium (RPMI1640 medium, supplemen-
ted with 10% human AB (HAB) serum, 5 mM L-glutamine,
50 U/ml penicillin and 50 μg/ml streptomycin (GIBCO® Invi-
trogen™) and 2 mg/ml fungin® (Invivogen, San Diego, CA,
USA)]. Differing combinations of recombinant IL-2 (200 IU/
ml; NIH AIDS Reagent Repository, Germantown, Maryland,
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ml; R&D Biosystems) were added to cultures (Table 1).
2.3. Isolation of peripheral blood mononuclear cells (PBMCs)
Whole blood was collected in ACD anti-coagulated
vacutainer tubes (BD Biosciences, Plymouth, UK). Peripheral
blood mononuclear cells (PBMC) were isolated by density
gradient centrifugation using Ficoll-Histopaque (Sigma-
Aldrich, Egham, Runnymede, UK) and LeucoSep® centrifuge
tubes (Greiner Bio-one, Frickenhausen, Germany).
2.4. Polyclonal expansion of PBMCs
Broad comparison of in vitro expansion methods were
initially performed using PBMCs because ex vivo cervical T cell
yield precluded comprehensive comparisons of methodology.
The two most efﬁcient methods for expanding PBMCs were
then applied to expand fresh cervical cytobrush-derived
mucosal cells. Brieﬂy, PBMCs from HIV-infected women were
subjected to the seven different expansion conditions de-
scribed in Table 1. PBMCs were added to respective wells at
1×105 PBMC/well in R10 medium. Expansion with each
method was performed in triplicate. Cells were cultured in a
5%CO2 at37 °C for 7 days and freshR10mediumwith cytokines
was replenished after every 2 days. Cells were removed for cell
counting on days 3, 5 and 7. When the cell density exceeded
2×106 cells/ml or when the medium became yellow, cultures
were split to a density of 0.5×106 cells/ml. Comparison of cell
yields and T cell viability was determined by Guava automated
cell counting (Guava Technologies, Hayward, CA, USA) and
Trypan staining using a Fast Read Haemocytometer by
microscopy (Sigma-Aldrich, Irvine, UK), respectively.
2.5. Collection and processing of cervical cytobrush specimens
Cervical cytobrush samples were collected from the female
genital tract of allwomenunder speculumexamination using a
Digene cervical sampler as previously described (Gumbi et al.,
2008; Iqbal et al., 2005; Nkwanyana et al., 2009; Passmore
et al., 2006). A Digene cytobrushwas inserted into the cervical
os and rotated 360° and immediately placed into 3 ml ice
transport R10 medium. The cervical cytobrushes were trans-
ferred to 4 °C in a Nalgene (Rochester, NY, USA) bench-top
cooler until transported to the laboratory. Cervical cytobrushes
with visible blood contamination were discarded (Passmore
et al., 2006). Cells were processed within 4 h of collection by
ﬂushing the cytobrush ∼30 times with R10. The cell suspen-
sionwas then transferred to a clean15 ml tube and centrifuged
at 1000×g for 10 min. The pelleted cells were resuspended in
500 μl R10. The absolute number of CD3+ T cells in each
cytobrush sample was counted using a Guava automated cell
counter (Guava Technologies) according to the method
described by Nkwanyana et al. (2009). Viability of cervical
mononuclear cellswas determined by Trypan staining (Sigma-
Aldrich, Irvine, UK) using a Fast Read Haemocytometer.
2.6. Polyclonal expansion of cervical cytobrush-derived T cells
Cervical T cells were expanded using either anti-CD3/IL-2,
Dynal (1:1)/IL-2 or Dynal (1:1)/IL-2/IL-7/IL-15. Cervical cellswere resuspended in R10 at 0.5–1×106 cells/ml and added to
each well at 100 μl/well. Due to limited cell numbers, cervical
cell expansions per donor were performed from multiple
donors, rather than as replicates. Cervical cells were cultured
as for PBMC.
2.7. Assessment of T cell maturational status by ﬂow cytometry
Distinct memory T cell subsets were identiﬁed by
differential staining with ﬂuorescent antibodies directed
against CD45RO, CCR7 and CD27. Cells were phenotyped on
days 0 and day 7 after expansion. The following antibodies
and ﬂuorochromes were used in this study: CD3-Allophyco-
cyanin-H7 (CD3-APC-H7), CD4-FITC, CD8-PerCp-Cy5.5,
CD27-PE (all BD Biosciences, San Diego, CA, USA), CCR7-APC
(R&D Systems, Minneapolis, MN, USA), CD45RO-Texas Red-
PE (Beckman Coulter, Marseille, France), CD14-PacBlue (BD
Biosciences San Diego, CA, USA), and CD19-PacBlue (Invitro-
gen, Carlsbad, CA, USA). Cells were stained with antibodies
directed at phenotypic (CD3, CD4, and CD8) andmaturational
markers (CD45RO, CCR7, and CD27). Violet amine reactive
dye (‘ViVid’; Invitrogen™ Molecular Probes™, Eugene, OR,
USA)was included in the staining protocol. Cells were stained
for 30 min and washed in wash buffer (1% FCS in PBS).
Approximately 200,000 events were acquired on an LSRII
ﬂow cytometer (BD Biosciences; San Jose, CA, USA). Data
analysis and colour compensation were performed using
FlowJo software v8.5.3 (Tree Star, Inc; Ashland, Oregon, OR,
USA). Dead cells (ViVid+), monocytes (CD14+), and B cells
(CD19+) were excluded from the analysis. Fluorescence
minus one (FMO) controls were used to set gates.
2.8. Statistical analysis
Statistical analyses were performed using GraphPad Prism
5® (GraphPad Software, San Diego California USA). The
Mann–Whitney U test was applied for independent sample
comparison, the Wilcoxon rank test was used for matched
non-parametric comparisons and Spearman ranks correlation
was applied for assessing the associations. p-values of ≤0.05
were considered signiﬁcant.
3. Results
3.1. Characteristics of women
EighteenHIV-infectedwomenwere included in this study to
compare methods for polyclonal expansion of T cells from the
female genital tract and blood (Table 2). Their median age was
34 years (range 26–43). They had amedian blood CD4 count of
396 cells/μl (range 302–811 cells/μl) and amedian plasma viral
load of 6000 RNA copies/ml (range undetectable — 170,000).
3.2. Comparison of polyclonal expansion methods for expanding
T cells from blood
We initially used PBMCs from HIV-infected women to
compare a broad panel of in vitro expansion methods because
ex vivo cervical T cell yield did not allow for such comprehen-
sive and parallel comparisons of methodology. We compared
the performance of seven different expansion protocols
Table 2
Clinical characteristics of HIV-infected women included in this study.
Group PID Age CD4 count
(cells/μl)
HIV viral load
(RNA copies/ml)
Ex vivo
cervical
cell count
Anti-CD3/IL-2 1 26 703 b50 117,320
2 26 384 13,000 96,800
3 33 465 170,000 110,800
4 42 601 b50 98,050
5 31 302 120,000 94,800
6 a 34 552 13,000 112,356
Dynal(1:1)/IL-2 7 33 473 b50 118,800
8 34 310 8100 121,800
9 43 605 b50 94,800
10 32 811 b50 156,000
11 36 389 b50 91,320
12 a 40 353 160,000 128,560
13 a 37 306 6000 132,000
Dynal(1:1)/IL-2/
IL-7/IL-15
14 41 396 1600 124,800
15 41 312 b50 112,800
16 31 302 120,000 92,800
17 40 401 22,000 142,000
18 36 308 16,000 101,320
Median 34 396 6000 112,800
Range 26–43 302–811 b50–170,000 91,320–
156,000
a Cervical cytobrush samples became contaminated during expansion.
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of Table 2; Fig. 1). Anti-CD3 and IL-2 treatment resulted in a
median of 4.5-fold (range 3.7–5.3) expansion of CD3+ T cells
in blood in 7 days (compared to day 0). Inclusion of anti-CD28
or addition of IL-7 and IL-15 to this combination did not
signiﬁcantly improve expansion (4.8-fold in the presence of
anti-CD28 and 5.1-fold in the presence of IL-7 and IL-15;
p=0.33 and p=0.18, respectively).
Dynal beads were tested at three bead-to-target cell ratios
(3:1, 1:1, and 1:5) and in the presence or absence of IL-7 and
IL-15 (Fig. 1). At all bead-to-target cell ratios tested, Dynal
bead expansion signiﬁcantly improved yields compared toFig. 1. Comparison of polyclonal expansion methods for expanding T cells from blo
protocols and cytokine cocktail: anti-CD3/IL-2 (dark blue), anti-CD3/anti-CD28/IL-2
beads (3:1)/IL-2 (yellow), Dynal anti-CD3/CD28 beads (1:5)/IL-2 (light orange), Dy
beads (1:1)/IL-2/IL-7/IL-15 (red). Bars represent the median of 5 donors' cell reco
measurements taken from ﬁve donors. The ﬁgures on top of the bars represent media
of day 0 and day 7 yields.immobilized anti-CD3 and IL-2 (p=0.008). The greatest
improvement in T cell yields was observed when an equal
number of Dynal beads-to-T cells (1:1) was used (6.7-fold
expansion with Dynal 1:1 compared to 4.5-fold for anti-CD3;
p=0.008). Addition of IL-7 and IL-15 in the presence of Dynal
beads (1:1) improved expansion yields slightly (7.1-fold;
p=0.3 compared to Dynal beads 1:1 and IL-2 alone).
None of the expansion methods assessed signiﬁcantly
impacted on the viability of PBMCs compared to day 0.
Compared to expansion with anti-CD3 and IL-2, expansion
with Dynal beads (1:1) and IL-2 both in the presence and
absence of additional IL-7 and IL-15 resulted in improved
PBMC viability [p=0.008 for Dynal+IL-2 alone and p=0.06
for Dynal+IL-2+IL-7+IL-15] (Table 3).
From these experiments, we concluded that Dynal beads
at a ratio of 1:1 in the presence of IL-2, IL-7 and IL-15
generated the greatest increase in CD3+ yield in 7 days.
To investigate the impact of HIV infection on in vitro
expansion kinetics, we compared the expansion kinetics of
PBMCs from 10 uninfected women (from Western Province
Blood Transfusion Services, Cape Town, South Africa) to
PBMCs from HIV-infected women (Table 4). While a similar
hierarchy of performance was observed for the 7 expansion
methods in HIV− comparedwith HIV± individuals, we found
that themagnitude of expansionwas 2–3-fold higher in HIV−
individuals than those infected with HIV (Table 4; p≤0.01).
This conﬁrms that HIV infection signiﬁcantly reduces the
polyclonal expansion efﬁciency of T cells and that the perfor-
mance of expansion methods would be better in uninfected
individuals.
3.3. Impact of polyclonal expansion of PBMCs on T cell memory
phenotype
We next investigated the impact of each expansion
method on blood memory T cell phenotypes based on
differential expression of CD45RO, CD27 and CCR7 (Fig. 2).od. PBMC were expanded using seven different combinations of expansion
(medium blue), anti-CD3/IL-2/IL-7/IL-15 (light blue), Dynal anti-CD3/CD28
nal anti-CD3/CD28 beads (1:1)/IL-2 (dark orange), and Dynal anti-CD3/CD28
very after 3, 5 and 7 days. Error bars represent the interquartile range for
n fold expansion after culturing. Wilcoxon rank test was used for comparison
Table 3
Impact of in vitro expansion methods on viability of PBMC.
Stimulus Cytokines cocktail Percentage viability following expansion p-value
Day 3 Day 5 Day 7
Median IQR Median IQR Median IQR
Anti-CD3 immobilized IL-2 86.2 (67.0–86.3) 83.9 (74.3–85.9) 79.2 (77.4–83.7) –
Anti-CD3 immobilized IL-2, IL-7, IL-15 85.9 (66.4–86.0) 84.0 (75.7–84.6) 82.7 (79.8–82.8) 1.0
Anti-CD3/anti-CD28 immobilized IL-2 73.1 (70.5–74.6) 81.4 (80.6–87.9) 85.3 (82.3–87.9) 0.22
Dynal anti-CD3/CD28 beads (1:5) a IL-2 84.4 (70.8–86.9) 84.1 (72.6–84.2) 81.0 (80.9–81.3) 0.5
Dynal anti-CD3/CD28 beads (1:1) IL-2 86.4 (85.6–87.4) 84.3 (83.1–84.3) 93.3 (76.5–95.7) 0.008
Dynal anti-CD3/CD28 beads (3:1) IL-2 84.8 (82.7–84.8) 74.1 (74.0–74.2) 71.8 (69.4–73.7) 0.5
Dynal anti-CD3/CD28 beads (1:1) IL-2, IL-7, IL-15 92.9 (90.8–94.1) 81.3 (79.2–81.7) 94.4 (87.1–95.0) 0.06
a Anti CD3/CD28 bead-to-T cell ratios. Median PBMC viability at day 0 was 94.5%.
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to deﬁne naive and total memory based on CD45RO and CD27
expression, while Fig. 2B shows the strategy used to deﬁne
distinct memory subsets. The following phenotypes were
deﬁned: naive T cells (CD45RO−CCR7+CD27+), intermedi-
ate memory T cells (CD45RO−CCR7−CD27+), effectors
(CD45RO−CCR7−CD27−), transitional memory T cells
(CD45RO+CCR7−CD27+), effector memory (CD45RO+
CCR7−CD27−), and central memory T cells (CD45RO+
CCR7+CD27+) (Burgers et al., 2009).
Before expansion, a median of 80% (range 65–91%) of
CD8+ T cells and 64% (range 46–81%) of CD4+ T cells were
antigen experienced (including CD45RO+ and CD45RO−
non-naive effector cells; Fig. 2C top panel). Following
expansion, we observed signiﬁcantly increased frequencies
(N95%) of both CD4+ and CD8+ T cells expressed CD45RO
following expansion (pb0.0001).
Since CD45RO+ memory T cells predominated in blood
following expansion, we further evaluated the impact of
expansion on distinct memory subsets (effector memory and
central memory, Fig. 2C middle and bottom panel). We found
that anti-CD3 and IL-2 stimulation (in the presence or
absence of anti-CD28 and/or IL-7 and IL-15) resulted in the
accumulation of cells with an effector memory phenotype
(CD45RO+CCR7−CD27−) compared with unexpanded
PBMC and cells expanded with Dynal beads (Fig. 2C). In
contrast to anti-CD3, Dynabeads expansions (with or without
IL-7 and IL-15) resulted in the accumulation of a central
memory phenotype. We noted that expansion of PBMC with
Dynal beads at a higher ratio of bead:PBMC (3:1 and 1:1)
resulted also in a signiﬁcantly higher proportion of cells with
a central memory phenotype, compared with unexpandedTable 4
Comparison of expansion kinetics of PBMC from HIV-infected and uninfected wom
Stimulus HIV-infected
Median (IQR)
N=5 (×106)
Anti-CD3+IL-2 0.42 (0.41–0.46)
Anti-CD3/CD28+IL-2 0.46 (0.40–0.46)
Anti CD3+IL-2+IL-7+IL-15 0.53 (0.51–0.55)
Dynal beads (3:1)+IL-2 0.59 (0.58–0.59)
Dynal beads(1:5)+IL-2 0.67 (0.64–0.67)
Dynal beads (1:1)+IL-2 0.67 (0.66–0.68)
Dynal beads (1:1)+IL-2+IL-7+IL-15 0.71 (0.70–0.74)PBMC (p=0.01 and p=0.03, respectively). Similar results
were observed for both CD4+ and CD8+ cells.
3.4. Comparison of methods for expanding cervical T cells
We obtained a median of 112,800 cervical cells (range
91,320–156,000) per cytobrush ex vivo from the 18 HIV-
infected women included in this study (Table 2). From the
results of the PBMC expansions, we selected the three best
performing methods [(1) anti-CD3/IL-2, (2) Dynal beads
(1:1)/IL-2, and (3) Dynal beads (1:1)/IL-2/IL-7/IL-15] to
expand cervical cytobrush-derived cells (Fig. 3). Fifteen of
18 cytobrushes (83.3%) expanded successfully while 3/18
(16.7%) became contaminated during culture (Table 2). This
resulted in ﬁve independent cytobrushes successfully ex-
panded for each of the three expansion methods tested
(Table 2). Despite a wide variation in HIV load (b50–170,000
RNA copies/ml), no signiﬁcant difference in the distribution
of viral loads between expansion groups was noted (data not
shown).
Expansion with anti-CD3 and IL-2 resulted in a median of
3.3-fold (range 2.2–5.7) increase in cervical CD3+ cells
following 7 days expansion with a median yield of 328,000
cells [range 236,000–538,600] and median viability of 87%
(range 84.5–89.5; Fig. 3; Table 5). Compared with anti-CD3
and IL-2 expansion, Dynal beads (1:1) and IL-2 resulted in a
signiﬁcant improvement in cervical cell yields with and
without additional cytokines IL-7 and IL-15 (p=0.004 and
p=0.04, respectively; Fig. 3). Dynal beads (1:1) and IL-2
alone yielded a median of 524,000 cells (range 396,000–
736,000) with a median of 4.7-fold increase and a median
cellular viability of 91.5% (range 90.25–93.5%). Dynal beadsen.
Uninfected
Median (IQR)
N=10 (×106)
Fold difference p-value
1.27 (1.23–1.28) 3.02 b0.01
1.28 (1.22–1.32) 2.78 b0.01
1.32 (1.28–1.46) 2.49 b0.01
1.39 (1.33–1.50) 2.36 b0.01
1.44 (1.28–1.58) 2.15 b0.01
1.56 (1.22–1.76) 2.33 b0.01
1.90 (1.83–2.17) 2.68 b0.01
Fig. 2. Impact of polyclonal expansion on T cellmemory phenotype in blood. Representative plots showing (A) naive and antigen-experienced cells (totalmemory) based on
differential staining with CD27 and CD45RO; and (B) differentiation markers expression (CD45RO, CD27, and CCR7) on CD8+ T cells from blood. Eight distinct memory
subsets were deﬁned from these markers: Central memory cells, (CD45RO+CD27+CCR7+), transitional memory cells (CD45RO+CD27+CCR7−), effector memory cells
(CD45RO+CD27+CCR7+), CD45RO+CD27−CCR7+, naive T cells (CD45RO−CD27+CCR7+), intermediatememory cells (CD45RO−CD27+CCR7−), effector (CD45RO−CD27−
CCR7−) andCD45RO−CD27−CCR7−cells. (C) Comparison of the frequency of total, effectormemory and centralmemory subsets expressed as percentages of total CD4+and
CD8+T cells in chronically HIV-infected individuals (n=5) before and after expansion using seven different protocols. Each box andwhisker plot shows themedian (central
line), IQR (outer lines of box) and 5–95% range (error bars) of 5 HIV-infected individuals. * indicates pb0.05 while ** indicates pb0.01 usingWilcoxon rank test.
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Fig. 3. Comparison of polyclonal expansion methods for expanding cervical cytobrush-derived T cells. Cervical cells obtained from HIV-infected women were
cultured with either anti-CD3/IL-2 (n=5; blue bars), Dynal anti-CD3/CD28 beads (1:1)/IL-2 (n=5; orange) and Dynal anti-CD3/CD28 beads (1:1)/IL-2/IL-7/IL-15
(n=5; red). Bars represent the yield of cells obtained from each donor pre- and post-expansion. Wilcoxon rank test was used to compare day 0 and day 7 yields.
Figures on top of the bars represent fold expansion relative to day 0.
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(range 496,000–756,000) with a median 5.6-fold increase.
Compared to expansion with anti-CD3 and IL-2, expansion
with Dynal beads (1:1) and IL-2 both in the presence and
absence of additional IL-7 and IL-15 resulted in improved
cervical T cell viability [p=0.09 for Dynal+IL-2 alone and
p=0.02 for Dynal+IL-2+IL-7+IL-15]. From these experi-
ments, we concluded that Dynal beads (1:1) in the presence
of IL-2, IL-7 and IL-15 generated the most signiﬁcant increase
in CD3+ T cell yields and viability in 7 days from cervical
cytobrush specimens compared to ex vivo yields (pb0.001).
3.5. Impact of expansion on memory T cell phenotype in the
female genital tract
We next investigated the impact of expansion on the
memory phenotype of T cells derived from the cervix (Fig. 4).
Fig. 4A shows a representative plot of the gating strategy used
to deﬁne cervical naive and total memory based on CD45RO
and CD27 expression, while Fig. 4B shows the strategy used to
deﬁne distinct memory subsets at the cervix. Before expan-
sion, we found amedian of 97.8% (range 66.7–100.0) of CD4+
T cells and 95.3% (range 80–100.0) of CD8+ T cells from theTable 5
Impact of in vitro expansion methods on viability of cervical cells.
Stimulus Cytokines cocktail Percentag
Day 0
Median
Anti-CD3 immobilized IL-2 98.0
Dynal anti-CD3/CD28 beads (1:1) a IL-2 94.0
Dynal anti-CD3/CD28 beads (1:1) IL-2, IL-7, IL-15 96.0
a Anti CD3/CD28 bead-to-T cell ratios.cervix that were antigen-experienced CD45RO+ T cells
(Fig. 4C, top panel). Signiﬁcantly more cells from the cervix
expressed CD45RO compared to blood for both CD4+
(p=0.0005) and CD8+ T cells (pb0.0001) reﬂecting the
trafﬁcking of antigen-speciﬁc cells to mucosal sites. We did
not observe any signiﬁcant change in the frequency of total
memory T cells before and after expansion from cervical
cytobrush-derived cells (Fig. 4C upper panel), since memory
T cells made up the majority of the population before and
after expansion. We evaluated the impact of expansion on
distinct cervical T cell memory subsets (effector memory, and
central memory; Fig. 4C; middle and lower panels respec-
tively). Expansion of cervical cells for 7 days with anti-CD3
and IL-2 resulted in signiﬁcantly increased frequencies of
effector memory CD8+ T cells compared to fresh cytobrush
samples (Fig. 4C). In contrast, Dynal bead (1:1) expansion
(with and without IL-7 and IL-15) resulted in signiﬁcantly
reduced frequencies of effector memory T cells (p=0.02 and
p=0.0005, respectively) for CD4+ T cells. While central
memory T cells comprised only 2.8% (range 0.0–11.1) of CD4+
and 0.3% (range 0.0–3.3) of CD8+ T cells before expansion, all
expansion methods resulted in enrichment for this memory
subset. In particular, expansion with Dynal beads (1:1) withe viability following expansion p-value
Day 7
IQR Median IQR
(96.0–100) 87.0 (84.5–89.5) –
(90.0–98.0) 91.5 (90.3–93.5) 0.05
(95.0–96.0) 96.0 (94.0–98.0) 0.02
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to 11.2-fold increase (pb0.0001) in the frequency of CD4+ T
cells and 81.1-fold (p=0.0002) to 154.3-fold increase
(pb0.0001) in the frequency of CD8+ T cells that were of a
central memory phenotype, respectively.
Fig. 5 provides a summaryof phenotypic changes following
expansion of PBMC and cervical cytobrush cells, including all
combinations of phenotypes observed with the markers we
used. While it is clear that effector memory T cells predom-
inate at the cervix ex vivo, effector and naive cells predominate
in fresh blood. Anti-CD3 expansion in the presence of IL-2
maintains this dominance of effector memory T cells in
cervical samples while it enriches for this population in
expanded PBMCs. In contrast, Dynal beads (particularly in the
presence of IL-7 and IL-15) favour the accumulation of central
memory subsets in both cervical and PBMC samples. The
transitional memory T cell frequencies were generally
unchanged irrespective of the expansion method used with
the exception of a signiﬁcant reduction in the frequency of this
subset in CD4+ T cells only following expansion with Dynal
beads (1:1) and IL-2, IL-7 and IL-15 (p=0.04; Fig. 5).
Based on signiﬁcantly improved cell yields and viability,
we concluded that the combination of Dynal beads (1:1) and
IL-2, IL-7 and IL-15 was superior to the other methods for
expanding both cervical and blood-derived T cells. This
method, however, selects for enrichment of central memory
over effector memory T cells in cervical samples, resulting in
expanded cervical cells differing from those present before
expansion. Although anti-CD3 and IL-2 offered the poorest
improvement in yield for both PBMC and cervical cells, this
method best conserved the memory proﬁle of cervical CD4+
cells following expansion (Fig. 5; Spearman rho=0.76;
p=0.04).
4. Discussion
Understanding T cell responses to HIV in the female
genital tract is important since the majority of new HIV
infections and transmissions are via this route. Isolation of
immune cells from the female genital tract using non-
invasive methods is characterized by low cell yields that
hamper thorough evaluation of immune function. Although
phenotypic and functional qualities of genital immunity have
previously been investigated ex vivo (Gumbi et al., 2008; Kaul
et al., 2000; Shacklett et al., 2000), there is a need to develop
methods to improve yields or expand immune subsets in vitro
(Ibarrondo et al., 2005; Iqbal et al., 2005; Shacklett et al.,
2003). Few studies have directly compared expansion
methods (Robinson et al., 2002; Kalamasz et al., 2004) or
compared their ability to expand cytobrush-derived T cells
from the female genital tract.
In this study, we compared the efﬁciency of immobilized
anti-CD3 alone or in combination with anti-CD28 and Dynal
bead-bound anti-CD3/CD28 to expand cervical cytobrush-
derived cells and PBMCs in the presence of various combina-
tions of γ-chain cytokines; IL-2, IL-7 and IL-15. We found that
Dynal beads in the presence of IL-2, IL-7 and IL-15 are
superior to other methods tested in terms of their ability to
expand both cervical and blood-derived T cells, but this
method enriched for central memory T cells. In contrast, anti-
CD3 and IL-2 offered the poorest improvement in yield forboth PBMC and cervical cells but best conserved the effector
memory proﬁle of cervical cells following expansion.
The strength and duration of signalling that T cells receive,
determines their fate (Kalamasz et al., 2004). Kalamasz et al.
(2004) reported that optimal expansion of T cells depends on
engagement of both the CD3/T cell receptor (TCR) complex
and co-stimulation with anti-CD28. In this study, the beneﬁt
of co-stimulation by the addition of anti-CD28 in the presence
of anti-CD3 and IL-2 did not signiﬁcantly improve expansion
yield of PBMCs nor alter the memory proﬁle of expanded cells
compared to anti-CD3 and IL-2 alone. Since expansion in
general selected for enrichment of thememory T cell pool and
memory T cells are known to have differing requirements for
co-stimulation than naive T cells, the inﬂuence of CD28 co-
stimulation in these experiments is likely to be dampened by
the reduced need of memory cells for this secondary signal
(Kalamasz et al., 2004; Sallusto et al., 2004).
We show that there are signiﬁcant changes that occur in
individual memory subsets depending on the expansion
method applied. Generally, anti-CD3 expansion in the
presence of IL-2 alone resulted in the accumulation of effector
memory cells, while Dynal beads resulted in selective
accumulation of central memory T cells from both cervix
and blood. Previous studies have shown that varying the
concentration of bead to target cells when using Dynal beads
impacts signiﬁcantly on expansion of naive versus antigen-
experienced cells with high bead:cell ratios favouring naive
cell expansion and low bead:cell ratios favour antigen-
speciﬁc cell expansion (Kalamasz et al., 2004). We found
that the highest yield of T cells was obtained at beads:cell
ratios of 1:1 followed by 1:5 and then 3:1, indicating that
bead-to-cell ratio impacted on expansion kinetics. This
ﬁnding supports previous observations that TCR signalling
strength is important in driving T cell proliferation (Kalamasz
et al., 2004). Further, we found that reducing the signal
achieved by reducing the beads-to-cell ratio resulted in
accumulation of effector memory T cells while increasing the
signal by increasing the beads-to-cell ratio favoured the
accumulation of central memory T cells. We speculate that
the differing phenotypes of T cells that result from the various
expansion protocols tested represent a change in the
phenotype of the cells present initially (activation induced
maturation and cycling) rather than a selective expansion of
an existing T cell population.
T cells derived from the female genital tract were
predominantly antigen experienced and more highly-differ-
entiated, with effector memory T cells being the most
predominant subset at the cervix. Effector memory cells
constitute the major population of CD4+ T cells in extra-
lymphoid effector sites such as the intestinal lamina propria
and the lung (Sallusto et al., 2004). The difference in the
memory status of T cells derived from cervical cytobrush
samples compared to bloodmay also explain the difference in
expansion potential of these cells. The female genital tract is
colonized by abundant commensal and sometimes patho-
genic microﬂora (Zhou et al., 2004). We speculate that
continuous exposure of immune cells residing in the genital
tract to bacterial products might result in increased T cell
activation, differentiation and exhaustion.
In this study, supplementation with IL-7 and IL-15
following stimulation with Dynal beads resulted in the
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Fig. 5. Summary of the phenotypic changes observed in distinct T cell subsets at the cervix and blood of HIV-infectedwomen. Eightmemory subsets were deﬁned from
thesemarkers: Central memory cells, (CD45RO+CD27+CCR7+), transitional memory cells (CD45RO+CD27+CCR7−), effectormemory cells (CD45RO+CD27+CCR7+),
CD45RO+CD27−CCR7+, naive T cells (CD45RO−CD27+CCR7+), intermediate memory cells (CD45RO−CD27+CCR7−), effector (CD45RO−CD27−CCR7−) and
CD45RO−CD27−CCR7−cells. Correlation between fresh and expanded cells memory phenotypes was performed using Spearman rank test and Spearman rho
and p-values for each correlation are shown above each pie chart.
77A. Bere et al. / Journal of Immunological Methods 354 (2010) 68–79accumulation of centralmemory T cells. Previous studies have
shown that these growth promoting cytokines override the
increased tendency of effector memory T cells to undergo
apoptosis (Sallusto et al., 2004), by inducing telomerase
activity (Son et al., 2000) and upregulating anti-apoptoticFig. 4. Impact of polyclonal expansion on T cell memory phenotype at the cervix. (A
memory) based on differential expression of CD27 and CD45RO. (B) Gating strategy u
cells (CD45RO+CD27+CCR7−), effector memory cells (CD45RO+CD27+CCR7+), C
memory cells (CD45RO−CD27+CCR7−), effector (CD45RO−CD27−CCR7−) and CD4
memory and central memory subsets expressed as percentages of total CD4+ and CD
and after expansion using three different protocols. Cervical cells were expand
[Dynal beads (1:1)/IL-2 and IL-2/IL-7/IL-15] and compared with anti-CD3/IL-2 alone
of box) and 5–95% range (error bars) of 5 HIV-infected individuals. * indicates pb0molecules (Boise et al., 1995). Addition of IL-7 and IL-15 in
combination with immobilized anti-CD3 resulted in selective
accumulation of effectormemory CD4+T cells, which is more
consistent with the reported tendency of these cytokines to
“protect” effector memory cells from apoptosis.) Representative plots showing naive and antigen-experienced T cells (total
sed to deﬁne central memory (CD45RO+CD27+CCR7+), transitional memory
D45RO+CD27−CCR7+, naive T cells (CD45RO−CD27+CCR7+), intermediate
5RO−CD27−CCR7− cells. (C) Comparison of the frequency of total, effector
8+ T cells at the cervix of chronically HIV-infected individuals (n=5) before
ed using the methods that yielded best expansion in PBMC experiments
. Each box and whisker plot shows the median (central line), IQR (outer lines
.05 while ** indicates pb0.01 using Wilcoxon rank test.
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expansion of cervical and blood-derived T cells from HIV-
infected women. We showed in blood that HIV-infection
impacts on the extent of expansion of T cells and is therefore
also likely to inﬂuence in vitro expansion of T cells from the
genital tract. We have previously shown that the memory
proﬁles of T cells isolated from the cervix of HIV-infected and
uninfected women are similar (Nkwanyana et al., 2009).
However, since (1) HIV infection may impact on the baseline
characteristics of cervical cells and their ability to expand
in vitro and (2) the value of this approach would be best
applied to uninfected HIV vaccine clinical trial participants, it
is likely that this data may under estimate the expansion
potential of T cells from the genital tract. It is therefore
important to expand these studies to include cervical T cell
expansion from HIV negative women.
Conditions that improve the rate of expansion and viability
of T cells derived from the female genital tract will not only
reduce the time required to improve yields but also reduce the
risk of expansion bias and contamination. We demonstrate
here that the extent of expansion of cervical T cells might be
impacted by the predominance of effector memory T cells
ex vivo. The relative expansion of cervical T cells expanded
with either anti-CD3/IL-2 or Dynal/IL-2 was 1.4-fold lower
than the extent of expansion observed for PBMCs. We
conclude that cervical T cell yields can be best improved by
expansion with Dynal beads (1:1) in the presence of IL-2, IL-7
and IL-15,whilememory T cell proﬁles can best bemaintained
by expansion with anti-CD3 in the presence of IL-2 alone.
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